Drug giant GlaxoSmithKline recently started the trial phase of its latest project, the world's first vaccine against malaria. In the largest drug trial ever, 16,000 children in Africa will be observed over 2 years. Half of them will receive the vaccine, and half will get the placebo. They will all be carefully monitored for signs of malaria. Research for this vaccine began in the late 1980s, and a recent donation by the Gates Foundation financed smaller trials of it. If this large-scale trial goes well, the vaccine could reach the markets by 2013.
Source: Wall Street Journal
Source: Wall Street Journal
Posts
